Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALKERMES PLC

(ALKS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ALKERMES PLC
07/21ALKERMES : to Report Second Quarter 2021 Financial Results on July 28, 2021
PR
06/30ALKERMES : Presented New Data Analysis on Healthcare Resource Use Among Veterans..
PR
06/23ALKERMES : Announces Former Professional Baseball Player CC Sabathia, as Spokesp..
AQ
06/22ALKERMES : Announces Former Professional Baseball Player, CC Sabathia, as Spokes..
PR
06/14ALKERMES : Stock Option and Incentive Plan, as amended (Form 8-K)
PU
06/14ALKERMES PLC. : Change in Directors or Principal Officers, Submission of Matters..
AQ
06/07ALKERMES : Presents New Data on Nemvaleukin Alfa at 2021 American Society of Cli..
AQ
06/05ALKERMES : ALKS FINAL_ASCO21 Nemva IR Call 6.4.21 9.00am.pdf
PU
06/03ALKERMES : to Take Part in the Goldman Sachs Annual Global Healthcare Conference
PR
06/02ALKERMES : Announces FDA Approval of LYBALVI for the Treatment of Schizophrenia ..
AQ
06/01ALKERMES : Announces FDA Approval of LYBALVI™ for the Treatment of Schizop..
PU
06/01ALKERMES PLC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/31ALKERMES : to Host Webcast With Expert Oncologist Panel to Discuss Data on Nemva..
AQ
05/20ALKERMES : Announces the Appointment of Emily Peterson Alva to its Board of Dire..
PU
05/20ALKERMES PLC. : Change in Directors or Principal Officers, Regulation FD Disclos..
AQ
05/20ALKERMES : Announces the Appointment of Emily Peterson Alva to its Board of Dire..
PR
05/14ALKERMES : Announces 2021 Alkermes Inspiration Grants Program to Support Innovat..
AQ
05/13ALKERMES : Announces 2021 Alkermes Inspiration Grants® Program to Support Innova..
PR
05/05ALKERMES : to Take Part in the BofA Securities 2021 Virtual Healthcare Conferenc..
PR
05/04ALKERMES : to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Con..
AQ
04/30ALKERMES PLC. : Entry into a Material Definitive Agreement, Regulation FD Disclo..
AQ
04/30ALKERMES : Announces Agreement with Sarissa Capital
PR
04/28ALKERMES : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
04/28ALKERMES : Q1 Earnings Snapshot
AQ
04/28ALKERMES PLC. : Results of Operations and Financial Condition (form 8-K)
AQ
04/28ALKERMES PLC : Reports First Quarter 2021 Financial Results
PR
04/27ALKERMES : Launches New Disease State Website to Offer Education About Alcohol D..
PR
04/27ALKERMES : Fiscal Year 2020 Irish Financial Statements
PU
04/27ALKERMES : Initiates ARTISTRY-6 Trial of Nemvaleukin Alfa Monotherapy in Patient..
PR
04/21ALKERMES : to Host Conference Call to Discuss First Quarter 2021 Financial Resul..
PR
04/20ALKERMES : Presents New Data From Psychiatry Portfolio at Virtual 2021 Congress ..
PR
04/13ALKERMES : Fiscal Year 2020 Irish Financial Statements
PU
04/07ALKERMES : Announces Clinical Trial Collaboration and Supply Agreement With MSD ..
PR
03/25ALKERMES : to Take Part in Stifel's 3rd Annual CNS Day
PR
03/25ALKERMES : Investor Day to Focus on Scientific Progress and Value Creation Strat..
PR
03/11ALKERMES : Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatm..
PR
03/04ALKERMES : to Hold Virtual Investor Day
PR
02/18ALKERMES : to Take Part in SVB Leerink 10th Annual Global Healthcare Conference
PR
02/11ALKERMES PLC : Reports Financial Results for the Fourth Quarter and Year Ended D..
PR
02/04ALKERMES : to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 F..
PR
01/14ALKERMES : NIDA-Funded Study Evaluating Extended-Release Injectable Naltrexone P..
PR
01/06ALKERMES : to Present at the 39th Annual J.P. Morgan Healthcare Conference
PR
01/06ALKERMES : Announces Updates to Executive Leadership Team
PR
2020ALKERMES : Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer..
PR
2020ALKERMES RESCHEDULES THIRD QUARTER 2 : 30 a.m. ET
PR
2020ALKERMES : to Host Conference Call to Discuss Third Quarter 2020 Financial Resul..
PR
2020ALKERMES : Presents New Clinical Data on ALKS 4230 in Mini Oral Presentation at ..
PR
2020ALKERMES : Presents New Psychiatry Data at Psych Congress 2020 Virtual Experienc..
PR
2020ALKERMES : to Take Part in Cantor Virtual Global Healthcare Conference
PR
2020ALKERMES : to Present New Data on Investigational Immuno-Oncology Candidate, ALK..
PR
2020ALKERMES : Initiates Phase 2 Study Designed to Evaluate Clinical and Immunologic..
PR
2020ALKERMES : Releases Third Annual Corporate Responsibility Report
PU
2020ALKERMES : to Host Conference Call to Discuss Second Quarter 2020 Financial Resu..
PR
2020ALKERMES : Announces Launch of 3rd Annual Alkermes Pathways Research Awards® Pro..
PR
2020ALKERMES : Awards COVID-19 Relief Fund Grants to 10 Innovative Programs Designed..
PR
2020ALKERMES : to Take Part in 41st Annual Goldman Sachs Global Healthcare Conferenc..
PR
2020ALKERMES : Presents New Data From Schizophrenia Portfolio at Virtual 2020 Congre..
PR
2020ALKERMES : Announces Expansion of Patient Services and Provider Network to Suppo..
PR
2020ALKERMES : Announces Upcoming Presentation at the Bank of America Securities Vir..
PR
2020ALKERMES : Launches COVID-19 Relief Fund to Support Innovative Programs Helping ..
PR
2020ALKERMES : Reports First Quarter 2020 Financial Results and Provides COVID-19 Re..
PR
2020ALKERMES : to Host Conference Call to Discuss First Quarter 2020 Financial Resul..
PR
2020ALKERMES : Announces Publication of Preclinical Data for ALKS 4230 in the Journa..
PR
2020ALKERMES' : Corporate Presentation to be Webcast at the Cowen and Company 40th A..
PR
2020ALKERMES : to Present at the 9th Annual SVB Leerink Global Healthcare Conference
PR
2020ALKERMES : Reports Financial Results for the Fourth Quarter and Year Ended Dec. ..
PR
2020ALKERMES : to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 F..
PR
2020ALKERMES' : Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan ..
PR
2019ALKERMES : to Present at the Evercore ISI 2nd Annual HealthCONx Conference
PR
2019ALKERMES : Completes Acquisition of Rodin Therapeutics
PR
2019ALKERMES : to Acquire Rodin Therapeutics
PR
2019ALKERMES' : Corporate Presentation to be Webcast at Upcoming Healthcare Conferen..
PR
2019ALKERMES : Announces New Data From ALKS 4230 Clinical Development Program at Soc..
PR
2019ALKERMES : to Present Data From ALKS 4230 Clinical Development Program at the So..
PR
2019ALKERMES : Reports Third Quarter 2019 Financial Results and Implementation of Re..
PR
1  2  3  4  5Next
Upcoming event on ALKERMES PLC
07/29/21
Upcoming sector events